Skip to main content
  • CV Risk in RA: Questions Remain

    — TARGET study should fill in the clinical gaps

    ORLANDO -- Evidence continues to grow supporting the concept that reducing inflammation in patients with rheumatoid arthritis (RA) will not only improve their articular symptoms but also lower their cardiovascular (CV) risk, a researcher said at the annual meeting of the Florida Society of Rheumatology here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details